BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.09B
AUM Growth
+$628M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
29
New
Increased
Reduced
Closed

Top Buys

1
+$63.6M
2
+$51.7M
3
+$18.2M
4
GILD icon
Gilead Sciences
GILD
+$14.1M
5
PBYI icon
Puma Biotechnology
PBYI
+$8.52M

Top Sells

1
+$40.7M
2
+$19.6M
3
+$18.3M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$10.2M

Sector Composition

1 Healthcare 81.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$415M 13.46%
3,714,298
-175,000
2
$369M 11.95%
5,976,526
-660,000
3
$296M 9.59%
4,051,867
-250,000
4
$278M 8.99%
2,945,596
+150,000
5
$209M 6.77%
1,864,921
-25,600
6
$161M 5.21%
1,354,445
7
$138M 4.47%
2,769,412
-90,000
8
$124M 4.03%
672,428
-55,000
9
$107M 3.47%
2,752,140
+7,100
10
$105M 3.4%
1,130,476
+37,000
11
$98.8M 3.2%
521,991
+45,000
12
$89.4M 2.9%
731,542
13
$81.2M 2.63%
198,000
-35,000
14
$79.8M 2.58%
651,181
+14,408
15
$72.9M 2.36%
751,288
-30,000
16
$69M 2.23%
3,086,552
-30,000
17
$65.9M 2.13%
6,825,532
+395,000
18
$63.6M 2.06%
+1,227,912
19
$51.7M 1.67%
+65,106
20
$46.8M 1.52%
395,000
+20,000
21
$39.2M 1.27%
2,320,737
22
$34.6M 1.12%
618,188
+60,000
23
$26.2M 0.85%
704,582
24
$19.8M 0.64%
3,240,816
+75,000
25
$18.2M 0.59%
+775,000
1
2